1. Fortifying the Treatment of Prostate Cancer with Physical Activity
   Colin E. Champ et al, 2016, Prostate Cancer CrossRef
2. MicroRNA-197 Mediates the Overgrowth and Anti-Apoptotic Effects by Downregulating Insulin-Like Growth Factor-Binding Protein-3 During Nephroblastoma Tumorigenesis
   Jinhua Hu et al, 2016, Fetal and Pediatric Pathology CrossRef
3. Revisiting the IGF-1R as a breast cancer target.
   Roudy Chiminch Ekyalongo et al, 2017, NPJ Precis Oncol CrossRef
4. Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway
   Zhanyu Wang et al, 2017, Oncotarget CrossRef
5. Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
   Nazanin Momeni Roudsari et al, 2021, Pharmaceutics CrossRef
6. Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging
   Dehong Cao et al, 2022, Front. Immunol. CrossRef
7. Insulin-like growth factor binding protein-3 mediates hyperosmolar stress-induced mitophagy through the mechanistic target of rapamycin
   Whitney Stuard Sambhariya et al, 2023, Journal of Biological Chemistry CrossRef
8. Intrinsic and extrinsic factors causing hyperplasia of the prostate
   Yuki Kyoda et al, 2024, Int J of Urology CrossRef
9. The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment
   Yudi Wang et al, 2024, Med Oncol CrossRef